Evidence map›Paper›PMID 39820401›Full record

ArticleThe journals of gerontology. Series B, Psychological sciences and social sciences2025

Loneliness and Biomarkers of Alzheimer's Disease, Axonal Damage, and Astrogliosis: A Coordinated Analysis of Two Longitudinal Cohorts.

Antonio Terracciano, Keenan A Walker, Yang An, Murat Bilgel, Angelina R Sutin, Martina Luchetti, Selin Karakose, Yannick Stephan, Kaj Blennow, Henrik Zetterberg and 7 more

Abstract read
In one paragraph

Article in The journals of gerontology. Series B, Psychological sciences and social sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Loneliness and Plasma Biomarkers of Neurodegeneration in Community-Dwelling Older Adults: Cross-Sectional and Longitudinal Analyses.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Antonio TerraccianoDepartment of Geriatrics, Florida State University College of Medicine, Tallahassee, Florida, USA.ORCID 0000-0001-5799-8885
Keenan A WalkerLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.ORCID 0000-0002-5989-9853
Yang AnLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Murat BilgelLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.ORCID 0000-0001-5042-7422
Angelina R SutinDepartment of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA.ORCID 0000-0002-1824-8974
Martina LuchettiDepartment of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA.ORCID 0000-0002-7370-8443
Selin KarakoseDepartment of Geriatrics, Florida State University College of Medicine, Tallahassee, Florida, USA.ORCID 0000-0001-8629-4422
Yannick StephanEuromov, University of Montpellier, Montpellier, France.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-3930-4354
Nicholas J AshtonDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
Thomas K KarikariDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.ORCID 0000-0003-1422-4358
Przemysław R KacDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
Abhay R MoghekarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Madhav ThambisettyLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.ORCID 0000-0002-2200-2299
Luigi FerrucciTranslational Gerontology Branch, National Institute on Aging, Baltimore, Maryland, USA.ORCID 0000-0002-6273-1613
Susan M ResnickLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 2020 to 2026
$29.3M
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
AD Strategic Fund and the Alzheimer's Association #ADSF-21-831376-CAlzheimer Drug Discovery Foundation #201809-2016862Alzheimer's Association 2021 Zenith Award ZEN-21-848495Alzheimer's Association 2022-2025 SG-23-1038904 QCBluefield ProjectCure Alzheimer's FundErling-Persson Family FoundationEuropean Union Joint Program for Neurodegenerative Disorders JPND2019-466-236European Union Joint Programme - Neurodegenerative Disease Research JPND2021-00694European Union's Horizon Europe research and innovation program 101053962Familjen Rönströms StiftelseFamiljen Rönströms Stiftelse, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden #FO2022-0270Hjärnfonden, Sweden #FO2017-0243Kirsten and Freddy Johansen FoundationLa Fondation Recherche AlzheimerMarie Skłodowska-Curie 860197National Institute for Health and Care Research University College London Hospitals Biomedical Research CentreNEuroBioStand #22HLT07NIA NIH HHS P30 AG066507NIA NIH HHS R01 AG083874NIH HHSOlav Thon FoundationSwedish Alzheimer Foundation #AF-930351Swedish government and the County Councils, the ALF-agreement #ALFGBG-715986Swedish Research Council #2017-00915Swedish Research Council (#2023-00356Swedish State Support for Clinical Research (#ALFGBG-71320UK Dementia Research Institute at UCL UKDRI-1003
6 · The paper itself

Abstract

objectivesLoneliness is associated with an elevated risk of dementia. There is mixed evidence from imaging studies on whether loneliness is associated with neuropathology in dementia-free adults. This study tests whether loneliness is associated with plasma neurobiomarkers of amyloid (Aβ42/Aβ40), phosphorylated tau 181 (pTau181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) and imaging measures of amyloid and tau.

methodsParticipants were cognitively unimpaired older adults from the Baltimore Longitudinal Study on Aging (BLSA; N = 1,028 individuals and up to 2,277 neurobiomarker measurements; Baseline mean age = 66, SD = 15 years) and the UK Biobank (N = 1,263 individuals and up to 2,526 neurobiomarker measurements; Baseline mean age = 60, SD = 7 years). Single-item measures of loneliness and the Quanterix Single Molecule Array assays were used in both samples. In a subset of BLSA participants, positron emission tomography (PET) was used to assess cerebral amyloid burden (n = 220) and tau in the entorhinal cortex (n = 102).

resultsIn both samples and meta-analyses, loneliness was unrelated to plasma measures of Aβ42/Aβ40, pTau181, NfL, and GFAP. Changes in loneliness were also unrelated to changes in the plasma neurobiomarkers, and no consistent evidence of moderation by age, sex, or APOE ε4 allele was found. Loneliness was also unrelated to PET-based measures of amyloid and tau. DISCUSSION: This study found no associations between loneliness and measures of Alzheimer's disease pathology, axonal damage, or astrogliosis.

Indexed as

Alzheimer DiseaseAxonsGliosisLonelinessAgedAged, 80 and overAgingAmyloid beta-PeptidesBiomarkersFemaleGlial Fibrillary Acidic ProteinHumansLongitudinal StudiesMaleMiddle AgedNeurofilament ProteinsAmyloid beta-PeptidesBiomarkersGlial Fibrillary Acidic Proteinneurofilament protein LNeurofilament ProteinsPeptide Fragmentstau ProteinsAmyloidGFAPLonelyNfLTau

Identifiers

PMID39820401
PMCPMC11898208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.